| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | UBS Views CKI HOLDINGS Sale of UKPN as Overall Positive, but ST Special Div. Unlikely | ||
| Fr | Citi Upgrades CK ASSET to Buy, Elevates TP to $54.55 | ||
| Fr | UBS: Sale of UKPN Positive for POWER ASSETS | ||
| Fr | HSBC Research Raises HKEX 2026/2027 Earnings Forecasts, Lifts TP to $520 | ||
| Fr | Dataforce: CN Automakers' Mkt Shrs in Europe Subside in Jan | ||
| Fr | BofAS: HKEX 2025 NP Largely in line | ||
| Fr | JPM Expects GALAXY ENT to Gradually Raise Div. in Future, Keeps Overweight Rating as Top Pick | ||
| Fr | SENSETIME-W, YOFC, HESAI-W Surge 3-7% as They Will Join MSCI CN Index After Mkt Close | ||
| Fr | JPM Expects NVIDIA Revenue Growth to Improve Next Yr, Raises TP to USD265 | ||
| Fr | HSBC Research: NVIDIA 4QFY26 Results Beat; Yet TP Cut to USD295 | ||
| Fr | JPM: HSBC HOLDINGS Mgmt Provides Clearer Insights into 2026-2028 Rev. Growth Trajectory | ||
| Fr | SENSETIME-W Launches Beauty Software Development Kit 'Beauty Agent' | ||
| Fr | GAC GROUP Targets to Return to Vehicle Production/Sales of 2M Cars This Yr | ||
| Fr | Taobao Instant Commerce, In Response to New Online Catering Rules, Establishes '3+1+AI' Food Safety System | ||
| Fr | Short Selling Turnover $21.6B, or 22.1% of Eligible Securities Turnover at Midday | ||
| Fr | Panamanian Prosecutors Search CKH's PPC Office, Seize Documents: Panamanian Newspaper | ||
| Fr | M Stanley's H-shr Focus List (Table) | ||
| Fr | M Stanley Lists Thematic Focus List- High Conviction Opportunities in APAC (Table) | ||
| Fr | 'Dongchedi' Explores HK IPO as Soon as This Yr, Aiming to Raise US$1-1.5B | ||
| Fr | HSI Gains 197 Pts at Midday as SHK PPT Swells ~7%; TENCENT/MEITUAN-W Boom | ||
| Fr | G Sachs Expects GALAXY ENT to Have Ample Financial Capacity to Further Hike Div., but Cuts TP to $53.4 | ||
| Fr | JPM: HKEX 4Q25 NP Beats; YTD ADT Rebounds; IPO Pipeline Accelerates | ||
| Fr | UBS: GALAXY ENT 4Q25 Adj. EBITDA in Line; Rating Buy | ||
| Fr | CLSA Favors CDMOs for Earnings Visibility, Top Picks WUXI APPTEC/WUXI BIO/PHARMARON | ||
| Fr | UBS Upbeat on BIDU-SW AI Biz Maintaining Strong Growth, Keeps Buy Rating |